# The Blood Center – FDA Inspection, Mar 9, 2022

Source: https://www.keypedia.com/records/fda_inspections/the-blood-center/33f7dbc6-bad2-4e38-a608-865986a2fee8
Source feed: FDA_Inspections

> FDA inspection 1166414 of The Blood Center, March 09, 2022. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166414
- Company Name: The Blood Center
- Inspection Date: 2022-03-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1063944 - 2018-07-25
- FDA Inspection 982410 - 2016-06-14
- [FDA Inspection 872717 - 2014-04-01](https://www.keypedia.com/records/fda_inspections/the-blood-center/f23c3b6d-a1e1-40c9-9bb6-1935eaea8db4)
- FDA Inspection 806794 - 2012-10-17
- FDA Inspection 708509 - 2011-01-26

Company: https://www.keypedia.com/companies/the-blood-center/19e79376-3ce4-4b69-9380-ace2ae41efcc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d